Approval Marks Numinus’ First use of Psilocybin-Assisted Therapy Treatment Outside of Clinical Trials VANCOUVER, BC –Numinus Wellness Inc. (“Numinus”) (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments… Read More
KIRKLAND, QUEBEC – Najah Sampson has been named President of Pfizer Canada ULC, effective May 16, 2022. Ms. Sampson will be succeeding Cole Pinnow, who has held the position since… Read More
Power up your resume and gain hands-on training with this 2-week laboratory course. Are you looking to expand your technical skills in the life sciences? Animal cell culture is an… Read More
Dr. Marisol Ochoa-Villareal joins the Company’s R&D Team in Germany Phyton Biotech, Ltd., a global leader in specialty fermentation solutions for naturally derived compounds and the largest global supplier of… Read More
Promising 12-week Phase II trial data with BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, published in The New England Journal of Medicine Potential new treatment for progressive pulmonary… Read More
